USFDANov 5, 2026, 09:12 AM
AIR Global Submits PMTA to FDA for Crown Switch Vape Platform
AI Summary
AIR Global PLC has submitted a Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) for its new rechargeable pod vape platform, Crown Switch. The application includes comprehensive scientific and technical data intended to demonstrate that the product is appropriate for the protection of public health. This submission marks a significant step in AIR's strategy to enter the regulated U.S. vaping market, leveraging technology from its strategic investment in Greentank. The company aims to offer adult smokers a distinct alternative to traditional cigarettes.
Key Highlights
- AIR Global PLC submitted a Premarket Tobacco Product Application (PMTA) to the U.S. FDA for its Crown Switch rechargeable pod vape platform.
- The PMTA includes extensive scientific evidence addressing product quality, manufacturing, consumer behavior, and population-level health impacts.
- Crown Switch utilizes Greentank's Quantum Vape technology, a chip-based aerosolization system.
- AIR Global previously made a $20 million strategic equity investment in Greentank in July 2026.
- The company believes Crown Switch offers adult smokers a differentiated alternative to combustible cigarettes.
- The submission is part of AIR's strategy to establish a responsible presence in the regulated U.S. vaping market.
Price Impact
More from AIIR